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Most of the gap junction proteins are regulated in part by post-translational phosphorylation. Phosphorylation has been shown to be
important in gap junction assembly and turnover, and for channel function in the resting state. Connexin phosphorylation may be altered by
the activation of intracellular signaling pathways in response to growth factors, tumor promoters, activated oncogenes, hormones and
inflammatory mediators. In some instances altered phosphorylation has been associated with changes in connexin function and in other cases
appears to be associated with changes in the levels of the connexin protein and/or mRNA. This review focuses on the role of tyrosine protein
kinases in the regulation of gap junctions. The literature is most extensive for connexin43 and those studies are reviewed here. A great deal
has been learned in recent years about how connexin43 is regulated by tyrosine kinase-dependent signaling pathways. These pathways are
often complex and to some extent are cell type- and stimulus-dependent. Although considerable progress has been made in unraveling the
cellular pathways that regulate connexin function, significant challenges remain to be addressed in identifying additional phosphorylation
sites and determining the stoichiometries of the phosphorylation events that regulate connexin function and it’s interaction with other cellular
proteins.
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Connexin proteins span the membrane four times, such
that the amino terminus, carboxyl terminus and an intracel-
lular loop are formed on the cytoplasmic side of the
membrane and two extracellular loops are formed on the
outside surface of the cell. Most of the connexin proteins are
phosphorylated in vivo, primarily on serine residues with
smaller amounts of phosphothreonine or phosphotyrosine
reported for some of the connexins. Connexin43 (Cx43) is
one of the most ubiquitously expressed connexins and much
is known about its phosphorylation. A basal level of serine
phosphorylation on at least five sites appears to be required
for the assembly and function of Cx43 gap junctions [1–5].
An increasing number of studies have implicated growth
factors, tumor promoters, oncogene protein kinases, hor-
mones and inflammatory mediators in the regulation of gap0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: aflau@crch.hawaii.edu (A.F. Lau).junctional communication (GJC) through phosphorylation
events occurring on the C-terminal portion of the protein,
f aa 236–382 [6–13]. A number of the serine kinases that
target Cx43 in stimulated cells have been identified
(reviewed in Ref. [14]) including PKC (Ser368 and
Ser372), MAP kinases (Ser255, Ser279, and Ser282),
cdc2/cyclin B (Ser255), and casein kinase I (Ser325,
Ser328 and Ser330). v-Src and v-Fps are two of the tyrosine
kinases that have been shown to target tyrosine residues in
Cx43.
Some of the phosphorylation-induced effects on Cx43
appear to occur directly, such as the tyrosine phosphoryla-
tion of Cx43 induced by v-Src and the physical interaction
of Cx43 with v-Src that is associated with the disruption of
GJC [15–17]. These events lead to a chronic and dramatic
down-regulation of GJC in v-Src cells [9–11]. In other
instances, a tyrosine kinase such as activated c-Src has been
implicated in intracellular signaling pathways that influence
Cx43 function, but tyrosine phosphorylation on Cx43 has
not been detected and the disruption of GJC may be
transient [18–21]. This suggests that the actions of c-Src
may be indirect in these cases and dependent on the
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mitogen-activated protein (MAP) kinase and protein kinase
C (PKC) to mediate the effects on GJC. In still other cases,
protein phosphorylation does not appear to be directly
involved in channel regulation, but rather there is a loss of
Cx43 from gap junction plaques in the plasma membrane
and this may be associated with a change in the levels of the
Cx43 mRNA [22–26]. The events that lead to these changes
in Cx43 expression are not well understood. Activation of
some intracellular signaling pathways has been shown to
up-regulate GJC, generally through an increase in Cx43
protein and mRNA. These effects may be more long-term,
occurring at 6 or more hours following the activation of
intracellular signaling [27,28]. The regulation of GJC
appears to be complex and has been difficult to dissect,
since multiple signaling pathways impinge on Cx43 in
different cell types and under different stimulatory condi-
tions. Some of the studies of the regulation of Cx43-
mediated GJC by activated tyrosine protein kinases are
described in the following sections of this review. They
represent some of the spectrum of signaling events that are
thought to be involved in the regulation of the Cx43 protein
and/or GJC.
This review focuses on the tyrosine kinase-dependent
phosphorylation of Cx43, because this represents one of the
better-understood mechanisms involved in the regulation of
GJC. Many growth factor receptors are tyrosine kinases, as
are oncoprotein kinases such as v-Src and v-Fps. In addi-
tion, the inhibition of protein tyrosine-phosphatases [29] has
been shown to alter Cx43 regulation. Key intracellular
signaling pathways utilize the actions of tyrosine protein
kinases/tyrosine protein phosphatases to exquisitely regulate
the transmission of molecular signals to downstream effec-
tors and adaptor proteins [30]. This is particularly important
to the regulation of normal cell growth, hyperproliferative
diseases such as cancer, gene transcription, the actions of the
insulin receptor, and the synchronization of contraction in
the heart and the uterus. Protein tyrosine kinases induce
protein–protein interactions through the creation of phos-
photyrosine binding sites for SH2- or PTB-containing
proteins [31–35]. This allows transmission of a signal from
an activated growth factor receptor to downstream kinases
that may mediate increased serine phosphorylation on Cx43.
Activation and autophosphorylation of the EGF receptor
tyrosine kinase provides phosphotyrosine-docking sites for
SH2-containing effector molecules like Grb2 and Shc and
leads to the activation of the Ras/Raf/MEK/MAP kinase
signaling pathway. In the case of v-Src, the direct phos-
phorylation of Cx43 on Tyr265 provides a docking site for
the SH2 domain of v-Src, leading to an enhanced interaction
with Cx43 and the phosphorylation of additional tyrosine
sites in Cx43 by the v-Src kinase. Many of the kinases that
are important to intracellular signaling pathways induce the
phosphorylation of Cx43 and may be involved in the
regulation of GJC. The cytoplasmic C-terminal domain of
Cx43 is particularly rich in potential kinase phosphorylationtarget sites and regulatory binding domains that may par-
ticipate in directing Cx43’s interactions with other cellular
proteins. Although there is a considerable body of data
available on the regulation of Cx43 and GJC by the tyrosine
protein kinases, there is some controversy associated with
this field and there are a number of areas where additional
careful studies are warranted.
This review does not cover some of the other aspects of
the regulation of gap junctions by protein phosphorylation.
Several recent reviews have addressed some of these other
areas of importance to this field, including the role of
protein phosphatases in the regulation of gap junctions
[14,29,36]. We have provided some background on the
subject of Cx43 phosphorylation, but have concentrated
on the more recent developments and more-studied exam-
ples of the regulation of Cx43 by tyrosine protein kinases.
We apologize in advance for the many studies that are not
discussed here and that have also provided important con-
tributions to the understanding of the regulation of GJC by
connexin protein phosphorylation.2. Non-receptor tyrosine protein kinases
Phosphorylation of Cx43 by the v-Src non-receptor
tyrosine kinase represents one of the most-studied examples
of how GJC is regulated by tyrosine protein kinases. In early
work, several laboratories demonstrated that activated non-
receptor tyrosine kinases, such as pp60v-src and p130gag-fps,
promoted Cx43 phosphorylation on tyrosine, and this was
associated with a marked disruption of gap junctional
intercellular communication [9–11,13]. v-Src and v-Fps
have some cellular substrates in common [37] and the
Cx43 protein may be an additional biologically relevant
substrate for both of these tyrosine kinases. Cx43 appeared
to be phosphorylated on similar sites in cells expressing
these oncoprotein kinases as demonstrated by the migration
patterns of tyrosine-containing tryptic peptides of Cx43 that
was isolated from 32Pi labeled cells [9].
2.1. v-Src-induced Cx43 phosphorylation
A Tyr265Phe mutant of Cx43 produced functional gap
junction channels when expressed in Xenopus oocytes, but
unlike the channels formed by the wild-type Cx43 protein,
these channels were not closed by the co-expression of the
pp60v-src kinase [13]. These data provided the first evidence
of the critical role for phosphorylation at the Tyr265 site of
Cx43 in the v-Src mediated disruption of GJC. Activated
pp60src appeared to directly phosphorylate Cx43 as demon-
strated by in vitro studies using purified proteins, and
phosphorylation occurred on tryptic peptides that co-migrat-
ed with a subset of the tryptic peptides obtained from Cx43
phosphorylated in vivo in Rat1 v-Src cells [16]. Consistent
with the hypothesis that Cx43 served as a direct substrate for
v-Src, Cx43 co-localized with the v-Src kinase at the plasma
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to interact directly with v-Src as demonstrated by reciprocal
co-immunoprecipitation studies in Rat1 v-Src cells [15,17].
The interactions of v-Src and Cx43 were found to be
dependent upon the intact SH3 and SH2 domains of v-Src,
and regions in the cytoplasmic C-terminal tail of Cx43, which
included a proline-rich region (Pro274–Pro284) and the
phosphorylated Tyr265 site [15]. Mutations in either the
SH3 or the SH2 domain of v-Src greatly reduced the
interaction of v-Src with Cx43 in co-transfected HEK293
cells as demonstrated by co-immunoprecipitation studies.
The mutations in these domains essentially abolished the
tyrosine phosphorylation of Cx43 in the v-Src expressing
cells (see Fig. 1). In addition, disruption of the proline-rich
region of Cx43 by the substitution of alanine for proline
residues also prevented the binding interactions of Cx43 with
v-Src. Furthermore, the Tyr265Phe Cx43 mutant failed to co-
immunoprecipitate with v-Src and was not significantly
phosphorylated on tyrosine in HEK293 cells that co-
expressed the v-Src kinase [15]. This observation suggested
that the Tyr265 site of Cx43was a key target for v-Src in vivo.
In contrast, the Tyr247Phe and Tyr267Phe Cx43 mutants
demonstrated significant tyrosine phosphorylation on Cx43
and were co-immunoprecipitated with v-Src from HEK293
cells that expressed these Cx43 mutants and v-Src. This
indicated that these two tyrosine sites in Cx43 were not likely
to be required for the binding interaction with v-Src.
More recent studies, carried out in Cx43 knockout mouse
fibroblasts that stably expressed exogenous wild-type or
mutant Cx43 have confirmed the Tyr265 in Cx43 as a siteFig. 1. The intact SH3 and SH2 domains of v-Src are required to mediate the int
Cx43. HEK293 cells were transiently transfected with Cx43 and either vector alone
W118R) or in the SH2 domain (Arg175Lys; R175K) or in both of these
immunoprecipitated from cell lysates and subjected to SDS-PAGE and Western blo
phosphotyrosine (pTyr), lower panels. Cx43 co-precipitated with wild-type v-Src, b
Cx43 that co-precipitated with v-Src contained phosphotyrosine, as shown in the
tyrosine phosphorylated in cells that expressed wild-type v-Src, but not in cells t
Reprinted from Ref. [15] with permission.that is phosphorylated by v-Src in vivo and identified the
Tyr247 site as a second site that is targeted by the v-Src
kinase [38]. Interestingly, phosphorylation of the Tyr265 site
alone, in cells that expressed the Tyr247Phe Cx43 mutant,
was not sufficient to induce channel closure in this mam-
malian cell system. This observation raised the possibility
that Cx43 phosphorylation may occur in a processive
manner with phosphorylation of the Tyr265 site occurring
first, creating a binding site for the SH2 domain of v-Src,
and strengthening the interaction of these proteins. This
facilitates phosphorylation of Cx43 at the Tyr247 site and
leads to the closure of the gap junction channels. Electro-
physiological studies by Cottrell et al. [39] using these
mouse fibroblasts have suggested that the reduction of
GJC by the v-Src-induced tyrosine phosphorylation of
Cx43 was not due to reductions in single channel amplitude
and may have been attributed to a reduction in P0 (channel
open probability) and changes in permselectivity.
However, the studies of Zhou et al. [40] have proposed a
different mechanism for the regulation of Cx43 channel
activity by v-Src. In their Xenopus oocyte system, junc-
tional conductance established by the Tyr265Phe and
Tyr247Phe single and the Tyr265Phe,Tyr247Phe double
Cx43 mutants was disrupted by v-Src expressed from the
injected RNA. This surprising result was interpreted as
evidence that these two tyrosine sites in Cx43 were not
required for the disruption of GJC induced by the v-Src
kinase [40]. A quadruple serine site mutant of Cx43
(Ser255Ala, Ser257Ala, Ser279Ala, Ser282Ala Cx43), that
lacked the MAP kinase phosphorylation sites, showed aeraction of v-Src with Cx43 and to induce the tyrosine phosphorylation of
(pCDNA3), v-Src, or v-Src with mutations in the SH3 domain (Trp118Arg;
domains (W118R/R175K). v-Src (panel A) and Cx43 (panel B) were
tting. The membranes were probed with antibodies to Cx43, top panels or to
ut not with v-Src with mutations in the SH3 or SH2 domains (panel A). The
lower part of panel A. Total Cx43 immunoprecipitated from these cells was
hat expressed v-Src with mutations in the SH3 or SH2 domains (panel B).
Fig. 2. A model for Cx43’s interaction with and phosphorylation by membrane localized v-Src. The interaction of Cx43 with v-Src at the plasma membrane
(PM) is initiated by the binding of the SH3 domain of v-Src to the proline-rich region of Cx43 (PXXP, Pro274–Pro284). This brings the kinase domain of v-
Src into proximity with the Tyr265 site of Cx43 (Y265) and allows phosphorylation at this site (P-Y265). The P-Y265 site of Cx43 provides a binding site for
the SH2 domain of v-Src, strengthening the interaction between these proteins and allowing for the subsequent phosphorylation at the Tyr247 site of Cx43
(pY247). This leads to closure of the Cx43 gap junction channel (depicted as a cylinder in this model). Reprinted from Ref. [38] with permission.
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the oocytes. This suggested a key role for MAP kinase-
mediated phosphorylation of Cx43 in the regulation of GJC
in the v-Src cells. Moreover, these investigators found that
a MEK inhibitor, PD98059, blocked the ability of v-Src to
disrupt GJC in LA25 rat fibroblasts that expressed a
temperature-sensitive form of v-Src. v-Src was rapidly
activated in these cells (within 5 min) by a shift to the
permissive temperature. The results with the MEK inhibitor
suggested that phosphorylation of Cx43 on serine, mediat-
ed by activated MAP kinase, and not the tyrosine phos-
phorylation of Cx43 by v-Src, was involved in the
regulation of GJC in the LA25 rat fibroblasts [40].
Currently, the reasons for these very different experimen-
tal results are not clear. In the presence of acutely expressed
v-Src from the transcription of microinjected RNA in
oocytes or induced by a temperature shift in LA25 rat
fibroblasts [40], the effects on GJC may be different than
those that occurred in cells with constitutive expression of a
non-temperature-sensitive v-Src, as in the mouse fibroblast
system [38]. In this latter study, treatment with a MEK
inhibitor, PD98059, did not block the ability of constitu-
tively expressed v-Src to induce channel closure in the cells
that expressed wild-type Cx43. This suggested that MAP
kinase activation and the possible serine phosphorylation of
Cx43 were not required for v-Src’s actions in this cell
system [38]. This conclusion was supported by additional
studies that utilized Cx43 knockout mouse fibroblasts that
expressed v-Src and a Cx43 mutant that lacked the MAP
kinase phosphorylation sites (Ser255Ala, Ser279Ala,
Ser282Ala).1 Cx43 was phosphorylated on tyrosine in these
cells and GJC was dramatically disrupted. This occurred in
the absence of possible phosphorylation at the MAP kinase
target sites. These results have provided additional direct1 Warn-Cramer, B.J. et al., manuscript in preparation.support for the view that MAP kinase-mediated phosphor-
ylation of Cx43 is not required for the effects of v-Src on
GJC and they have supported the role for tyrosine phos-
phorylation of Cx43 in the disruption of GJC in v-Src cells.
Studies that have identified the tyrosine sites of Cx43
that are targeted by v-Src and the protein domains that are
required for the binding interaction of these proteins have
suggested a possible model for the events that lead to the
disruption of GJC [15,38]. In this model, the SH3 domain of
v-Src initially binds to the proline-rich region in Cx43
(Pro274–Pro284) and brings these two proteins into close
proximity (see Fig. 2). This results in phosphorylation of the
Tyr265 site in Cx43 by the v-Src kinase domain and
generates a second binding site in Cx43 that interacts with
the SH2 domain of v-Src and stabilizes the protein interac-
tion. The induced protein proximity leads to the processive
phosphorylation of Cx43 at the Tyr247 site and this leads to
the disruption of GJC. This model suggests that the phos-
phorylated Tyr265 site may be important as a binding site
that strengthens the interaction of Cx43 with v-Src, whereas
phosphorylation of Tyr247 may promote the closure of the
Cx43 channels. The requirement for phosphorylation at the
Tyr265 site in order to promote efficient phosphorylation of
the Tyr247 site was supported by the observation, that in the
absence of the Tyr265 site, Cx43 isolated from the v-Src-
expressing cells contained significantly reduced levels of
phosphotyrosine (f 10%) compared to the wild-type pro-
tein [38] (see Fig. 3).
These data and the working model described above
raise the question of how the phosphorylated Tyr265 and
Tyr247 sites of Cx43 cooperate to induce the closure of the
Cx43 channels, since phosphorylation at either site alone
was not sufficient to induce channel closure [38]. Data
obtained in one study has demonstrated the ability of the
C-terminal tail of Cx43 to promote the closure of the gap
junction channels by v-Src, when introduced as a separate
Fig. 3. Mutation of the Tyr265 site of Cx43 greatly reduced tyrosine
phosphorylation of Cx43 in v-Src cells. Cx43 was immunoprecipitated
from Cx43 knockout cells expressing wild-type or mutant Cx43 under
conditions of antigen excess and analyzed by SDS-PAGE and Western
blotting for phosphotyrosine (pTyr) content, upper panel. The levels of pTyr
in the Cx43 mutants were quantified in two experiments relative to the
controls; wild-type Cx43 without v-Src (wtC1 cells, 0% pTyr) or with v-Src
(wtS2 cells, 100% pTyr), see bar graph. In the absence of the Tyr265 site
(265FS1 cells), tyrosine phosphorylation was greatly reduced to f 10% of
wild-type Cx43 and was further reduced to ~2% in the double tyrosine site
Cx43 mutant (dbS2 cells; Tyr265Phe, Tyr247Phe) in the v-Src cells. This
demonstrated a key role for the Tyr265 site in the interactions of Cx43 with
v-Src. The Tyr247Phe mutant expressed with v-Src (247FS2) demonstrated
f 57% of the pTyr content relative to wild-type Cx43 and phosphorylation
presumably occurred largely at the Tyr265 site. Reprinted from Ref. [38]
with permission.
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form of Cx43 (truncated at Asp245) [40]. Regions of the
Cx43 cytoplasmic C-terminal tail between amino acids 241
and 280 appeared to mediate this sensitivity to v-Src. This
important demonstration of a reconstituted system has
provided support for the concept that Cx43 channel closure
induced by v-Src phosphorylation may be mediated
through a ‘‘ball-and-chain’’ or ‘‘particle-receptor’’ type of
mechanism, as has been proposed for the pH- and insulin-
induced Cx43 channel gating [12,41]. The specifics that
underlie the mechanisms of the phosphorylation-induced
Cx43 channel closure are significant issues that must be
addressed in order to fully understand how GJC is regu-
lated by protein phosphorylation.
2.2. c-Src induced Cx43 phosphorylation
In early studies, it was demonstrated that over-expression
of c-Src induced a moderate fall in GJC in NIH3T3 cells,
whereas the expression of a kinase-active mutant of c-Src
(the Tyr527Phe mutant) induced a dramatic fall in GJC [42].
In additional studies, it was demonstrated that a constitu-tively active mutant of c-Src, but not a kinase-dead mutant,
interacted with and phosphorylated Cx43 in co-transfected
COS-7 cells [43]. GJC was disrupted in the cells that were
co-transfected with wild-type Cx43 and activated c-Src and
a direct interaction of Cx43 with activated c-Src was
demonstrated by co-precipitation of the proteins. Mutation
of the Tyr265 site to phenylalanine abolished both the
tyrosine phosphorylation of Cx43 and the co-precipitation
of Cx43 with activated c-Src. These studies demonstrated
that Cx43 is a substrate for activated c-Src and provided
additional support for the role of the Tyr265 site and
tyrosine phosphorylation of Cx43 in the disruption of GJC
induced by the c-Src tyrosine kinase. Toyofuku et al. [44]
have demonstrated an increase in c-Src activity and tyrosine
phosphorylation of Cx43 in a hamster model of cardiomy-
opathy. These investigators expressed activated c-Src in
cardiomyocytes and demonstrated a reduction in GJC that
was correlated with the tyrosine phosphorylation of the
Cx43 protein. These studies indicated that c-Src tyrosine
phosphorylation of Cx43 may occur in vivo and the result-
ing disruption of GJC may contribute to the electrical
coupling abnormalities that have been observed in cardio-
myopathy.
c-Src has also been implicated in the ability of G protein-
coupled receptors to induce the disruption of Cx43-mediat-
ed GJC in Rat-1 cells [18]. G protein-coupled receptors lack
an intrinsic kinase activity, but are coupled to downstream
signaling events, such as the activation of c-Src and MAP
kinase, through an interaction with heterotrimeric G pro-
teins. In studies with lysophosphatidic acid (LPA) and
thrombin, physiological activators of G protein-coupled
receptor signaling, the downstream signaling events were
found to be independent of Ca2 + mobilization and the
activation of PKC, MAP kinase, Rho, or Ras [18]. Instead,
the activated G protein-coupled receptors appeared to re-
quire the kinase activity of c-Src to induce the changes in
Cx43 channel activity. These effects of G protein-coupled
receptor signaling on GJC were prevented in cells that
expressed a dominant negative form of c-Src, in Src-
deficient fibroblasts, and in cells pretreated with tyrosine
kinase inhibitors. These studies supported a key role for the
activity of the c-Src kinase in mediating the effects of
signaling on Cx43 function. The actions of c-Src in this
experimental system may have been indirect since tyrosine
phosphorylation of Cx43 was not detected [18]. In other
studies, Hii et al. [45] and Warn-Cramer et al. [46] have
demonstrated a role for MAP kinase in mediating the LPA-
induced phosphorylation of Cx43. Whether c-Src kinase
activity is required for MAP kinase activation and whether
MAP kinase phosphorylation of Cx43 affects GJC in this
system is not known. Additional studies will be required to
identify the kinase(s) activated by G protein-coupled recep-
tor signaling that are directly responsible for mediating
Cx43 phosphorylation and to determine whether the in-
creased Cx43 phosphorylation occurs on tyrosine or serine
sites and if this phosphorylation induces channel closure.
2 Jin, C. et al., manuscript submitted for publication.
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increase Cx43 phosphorylation in Rat-1 [18] and human
ovarian carcinoma cells [47]. In the ovarian cells, a transient
tyrosine phosphorylation of Cx43 and a decrease in gap
junction plaques were also observed. ET-1 and its’ G
protein-coupled receptor, ETAR, are increased in primary
and metastatic ovarian carcinoma cells and the ET-1-in-
duced disruption of GJC may contribute to the deregulation
of growth in these cells. ET-1-induced disruption of GJC
was blocked by pretreatment with tyrphostin 25 or the Src
family kinase inhibitor, PP2, suggesting a role for an Src
family kinase in the ET-1 induced tyrosine phosphorylation
of Cx43.
Lipopolysaccharide (LPS) treatment of primary micro-
vascular endothelial cells isolated from rat skeletal muscle
stimulated a reversible tyrosine kinase-dependent reduction
in gap junctional coupling [20]. This functional loss was
accompanied by tyrosine phosphorylation of Cx43, as
shown by immunoblotting studies with a phosphotyrosine
antibody and by direct phosphoamino acid analysis. Little
change was observed in the phosphoserine content of Cx43
from the treated cells [20]. Although the tyrosine kinase
involved in these effects of LPS was not identified, data
obtained with the use of chemical inhibitors suggested the
participation of an Src family member. In addition, treating
the cells with tyrosine phosphatase inhibitors accentuated
the tyrosine phosphorylation of Cx43 and the disruption of
GJC in this system [20].
The proinflammatory cytokine, TNFa has been reported
to differentially regulate GJC in human airway epithelial
cells and c-Src has been implicated in the effects on Cx43
[21]. TNFa increased the activation of c-Src in the airway
epithelial cells. Expression of a dominant negative form of
c-Src prevented the TNFa-induced channel closure where-
as, the expression of activated c-Src abolished GJC in these
cells. The transient expression of a Cx43 mutant that lacked
the Src phosphorylation sites (Tyr247Ala, Tyr265Ala) in the
airway cells, prevented the TNFa-induced effects on GJC.
Since wild-type Cx43 was also expressed in these cells,
these data are somewhat difficult to interpret. However,
these studies have supported a key role for c-Src in the
disruption of GJC induced by TNFa, although the tyrosine
phosphorylation of Cx43 was not demonstrated [21]. Thus,
it appears that both of these inflammatory agents, LPS and
TNFa, induced the disruption of GJC through a c-Src
kinase-dependent pathway.
Hypoxia and reoxygenation has been shown to induce a
transient fall in GJC and tyrosine phosphorylation on Cx43
in human umbilical vein endothelial cells [48]. These effects
were prevented by pretreatment with the tyrosine kinase
inhibitor genestein and enhanced by treatment with the
phosphatase inhibitor, vanadate, implicating a tyrosine ki-
nase in the effects on Cx43. Treating hamster embryo
fibroblasts with pervanadate or permolybdate, potent protein
tyrosine phosphatase inhibitors, induced increased phospho-
tyrosine on a number of cellular proteins, including Cx43,and a decrease in the non-phosphorylated isoform of Cx43
[49]. Whether this induced phosphorylation on Cx43 was
due to the inhibition of the dephosphorylation of a transient
low level of tyrosine phosphorylation that occurs in normal
cells or was due to the activation of an Src family kinase is
not known.
Another manner in which the Src tyrosine kinase may
regulate Cx43 is illustrated by the studies of Toyofuku et al.
[23]. These investigators reported that the expression of an
activated form of c-Src in rat neonatal cardiac myocytes
inhibited the endogenous interaction that occurred between
Cx43 and the tight junction-associated protein, ZO-1. The
disruption of the binding of ZO-1 to Cx43 appeared to
depend upon the competitive binding of the SH2 domain of
activated c-Src to Cx43, since ZO-1 binding was not lost in
cells that expressed activated c-Src and a Tyr265Phe Cx43
mutant. These studies indicated that the phosphorylation
state of Cx43 might be important for its interaction with
other cellular proteins. In other studies, Jin et al. have
demonstrated that Cx43 phosphorylation is altered when
the binding interaction with ZO-1 is disrupted.2 Thus, the
phosphorylation-dependent loss of binding interactions or
the formation of new binding interactions may result in
altered regulation of the Cx43 protein. It is also interesting
to note that the changes in Cx43 phosphorylation and ZO-1
binding that were observed in the HEK293 cells expressing
activated c-Src, correlated with a down-regulation of the
total and plasma membrane-localized Cx43 protein and with
the inhibition of GJC [23]. This suggested that Cx43
stability might have been altered by the tyrosine phosphor-
ylation of Cx43 and/or by the loss of Cx43’s interaction
with the ZO-1 protein.3. Receptor tyrosine protein kinases
3.1. EGF receptor tyrosine kinase
The epidermal growth factor (EGF) receptor is a trans-
membrane tyrosine protein kinase that undergoes homo- or
heterodimerization on ligand binding, resulting in receptor
autophosphorylation and the activation of its tyrosine kinase
activity [50]. Activation of the EGF receptor is important for
mitogenesis and cell differentiation and in tumorigenesis,
where over-expression of the receptor is associated with
enhanced cell proliferation. Tyrosine phosphorylation of
residues in the C-terminus of the receptor provides docking
sites for the assembly of signaling complexes through the
binding of SH2 and PTB domains in adaptor proteins [34].
Four family members have been described, Erb1, Erb2/neu,
Erb3 and Erb4. EGF and TGFa are the primary ligands for
Erb1. A ligand for Erb2 has not been identified and it is
most likely activated as a heterodimer with another Erb
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tumorigenic [51]. Erb3 and Erb4 are both activated by
neuregulin (heregulin). Although Erb3 has little functional
activity, it serves to activate Erb2 in a heterodimer on
binding to neuregulin. Many breast cancer cell lines have
also been found to over-express the EGF receptor and c-Src
and these tyrosine kinases function synergistically to en-
hance the growth of mammary epithelial cells [52].
In many cases, the EGF-induced activation of the EGF
receptor tyrosine kinase (Erb1) has resulted in a rapid and
transient disruption of GJC and a transient increase in Cx43
phosphorylation. This induced phosphorylation occurred on
serine residues and not on tyrosine, indicating that the EGF
receptor did not phosphorylate Cx43 directly [24,53,54].
The disruption of GJC appeared to be independent of a
significant loss of Cx43 from the gap junction plaques. EGF
induced a disruption of Cx43 function in T51B rat liver
epithelial cells that was determined to be independent of
PKC activity, but required the downstream activation of
MAP kinase [54]. MAP kinase phosphorylated Cx43 di-
rectly in in vitro reactions using purified proteins and
phosphorylation occurred on tryptic peptides that co-migrat-
ed with a subset of the phosphotryptic peptides of Cx43
obtained from the EGF-treated cells [54]. Later studies
identified Ser255, Ser279, and Ser282 of Cx43 as the target
phosphorylation sites for activated MAP kinase in vitro [55]
and demonstrated that these sites appeared to be targets for
MAP kinase in vivo [46]. A triple phosphorylation site
Cx43 mutant (Ser255Ala, Ser279Ala, Ser282Ala Cx43),
introduced into cells that lacked Cx43, retained the ability
to establish functional gap junction channels, but theseFig. 4. A model for Cx43’s interaction with the tyrosine kinases v-Src and the EGF
in the C-terminus of the protein. Whereas, the ligand-induced activation of the EG
phosphotyrosine binding sites for SH2 and PTB containing adaptor proteins such a
or the c-Src/MEKK2/MEK5/Erk5 signaling pathways [105] and induces serine p
v-Src or serine phosphorylation of Cx43 by EGF receptor-induced activation of dchannels were resistant to the MAP kinase-mediated dis-
ruption of GJC induced by activation of the EGF receptor
[46]. Fig. 4 depicts a model for EGF receptor-induced
phosphorylation of Cx43 on serine residues that is mediated
by the downstream activation of MAP (Erk) kinases through
the activation of the Ras/Raf/MEK/Erk signaling pathway.
To address the mechanism of the EGF-induced regulation
of GJC, Cottrell et al. [39] carried out electrophysiological
studies in EGF-treated Cx43 knockout mouse fibroblasts
that expressed exogenous Cx43. These studies indicated that
the ability of the activated EGF receptor to induce gap
junction channel closure was not attributed to a reduction in
the unitary conductance, but rather may have been due to a
reduction in P0 channel open probability [39]. Similar
results were obtained in the mechanism of the v-Src-induced
channel closure. However, the closure of Cx43 channels by
activated PKC appeared to result from a reduction in the
channel unitary conductance [56]. These studies have sug-
gested that Cx43 channel function may be regulated differ-
ently by phosphorylation events that occur at different sites
in the C-terminal tail of Cx43.
In another study, Cx43 hemichannels were reconstituted
into unilamellar lipid vesicles and were determined to be
permeable to sucrose or lucifer yellow dye. When these
vesicles were dephosphorylated by treatment with calf
intestinal phosphatase, the permeability of the liposomes
was increased. Treatment of the phosphatase-treated lip-
osomes with purified, activated MAP kinase (Erk2) induced
Cx43 phosphorylation and this resulted in a reduction in the
permeability of the Cx43 hemichannels in the reconstituted
system [57]. These data confirmed that Cx43 was a directreceptor. In this model, v-Src directly phosphorylates Cx43 on tyrosine sites
F receptor leads to autophosphorylation of the receptor and the formation of
s Grb2/SOS. This leads to the activation of the Ras/Raf/MEK/Erk [34] and/
hosphorylation on Cx43 [46,55,61]. Tyrosine phosphorylation of Cx43 by
ownstream kinases is associated with the disruption of GJC.
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mediated phosphorylation on Cx43 was sufficient to
down-regulate Cx43 function.
In other studies, Leykauf et al. [58] examined Cx43
phosphorylation in EGF-treated WB-F344 rat liver epithe-
lial cells using a phospho-specific peptide antibody that
recognized the phosphorylated Ser279 and Ser282 sites of
Cx43. This antibody recognized the most phosphorylated
isoform of Cx43 that was isolated from the EGF-treated
cells. Pretreatment with an EGF receptor inhibitor prevented
the increased Cx43 phosphorylation and pretreatment with
the PD98059 MEK inhibitor partially inhibited the EGF-
induced Cx43 phosphorylation. These data were consistent
with MAP kinase-mediated phosphorylation of Cx43 at the
Ser279 and Ser282 sites in the EGF-treated cells. This
antibody was used, together with an antibody that recog-
nized all forms of Cx43, for confocal studies of Cx43
localization and these studies demonstrated that differential-
ly phosphorylated isoforms of Cx43 coexisted in the plasma
membrane [58]. Interestingly, treating these cells with
anisomycin, which is known to activate the stress-activated
kinase p38 MAP kinase, but not Erk1/2 kinases, also
induced the weak recognition of a Cx43 band by the
phospho-specific peptide antibody. This suggested that the
Ser279 and/or Ser282 sites of Cx43 might also be a target
for other non-Erk1/2 kinases [58]. This antibody will be
very useful in examining the site-specific phosphorylation
of Cx43 following the activation of different cellular sig-
naling pathways that induce the activation of MAP kinase.
Polontchouk et al. [59] have also suggested a role for
Erk1/2 and p38 MAP kinase in the regulation of Cx43 in
cardiomyocytes following the activation of the endothelin 1
and angiotensin II G protein-coupled receptors. In addition,
JNK, another stress-activated kinase, has been implicated in
the regulation of Cx43 in cardiomyocytes, but this appears
to occur through the down-regulation of the Cx43 protein.
This decrease in GJC may be a contributing factor for
cardiac dysfunction in the failing heart [60]. These studies
have supported a role for other MAP kinase family members
in the regulation of Cx43.
A very recent study by Cameron et al. [61] has raised
questions about the role of MAP kinase in mediating the
disruption of GJC in EGF-treated cells. These investigators
reported that Erk5/BMK-1 (big MAP kinase-1) also phos-
phorylates Cx43 on the Ser255 site and that it is this
phosphorylation event that is associated with the disruption
of GJC in the EGF-treated cells. In light of reports that the
PD98059 MEK inhibitor, originally thought to be specific
for MEK1, also inhibits MEK5 and the downstream activa-
tion of Erk5 [62], these investigators examined the role for
Erk5 in the EGF-induced disruption of GJC. They found
that pretreatment with the PD98059 inhibitor blocked Erk1/
2 and Erk5 activation in EGF-treated HEK293 cells that
exogenously expressed Cx43. The expression of a consti-
tutively active form of MEK5, but not a constitutively active
form of MEK1, induced uncoupling of GJC in these cells.Erk5 was also shown to interact directly with Cx43 in vivo
by co-immunoprecipitation studies in over-expressing cells
[61]. Whether Erk1/2 and Erk5 both phosphorylate Cx43 in
vivo under different conditions or in different cell types
remains to be determined (see Fig. 4). These kinases have
similar active sites but appear to differ in their substrate
specificities. Previous reports have shown that cdc2/cyclinB
also induces the phosphorylation of Cx43 at the Ser255 site
in mitotic cells [63], and this may be correlated with the
down-regulation of GJC during the G2/M phase of the cell
cycle. Thus, there appears to be a number of protein kinases
that can target the Ser255 site of Cx43. This serine site may
be an important regulatory site in Cx43 that is targeted by
different kinases, at different stages of the cell cycle, and by
the activation of different intracellular signaling pathways.
To further complicate the understanding of how the
activation of the EGF receptor regulates GJC, EGF treatment
has been reported to enhance GJC in human kidney epithelial
K7 cells [22]. In these cells, TPA and EGF both induced the
activation of p42MAP kinase and induced similar patterns of
phosphorylation on Cx43, but these agents had opposite
effects on GJC. The enhancement of GJC induced by EGF
occurred after 2–3 h and thus, may have involved altered
Cx43 protein synthesis or transport rather than the increased
serine phosphorylation on Cx43, which appeared to occur
rapidly and to be complete after approximately 15 min.
In addition, Diez et al. [64] have reported that the EGF
receptor, isolated from rat liver membranes, directly phos-
phorylated Cx32 isolated from the same membrane prepa-
rations on tyrosine residues. Tyrosine phosphorylation
appeared to be very inefficient in this cell-free system and
contamination with another tyrosine kinase in these prepa-
rations is a possibility. It remains to be seen whether the
EGF receptor directly phosphorylates Cx32 in vivo under
physiological conditions and whether this phosphorylation
regulates Cx32 function.
3.2. MAP kinase-mediated serine phosphorylation of Cx43
The phosphorylation of Cx43 by MAP kinase, activated
downstream of a receptor tyrosine kinase or v-Src, has been
discussed in the preceding paragraphs. Other studies have
described the abilities of diverse stimuli to activate MAP
kinase and induce Cx43 phosphorylation. Treating WB-
F344 rat liver epithelial cells with TPA activated Erk1/2,
increased Cx43 phosphorylation, and blocked dye transfer
in these cells [65]. The down-regulation of dye coupling by
TPA was correlated with an apparent loss of gap junction
plaques from the plasma membrane rather than with Cx43
channel gating. TPA treatment also reduced GJC in IAR6.1
rat liver epithelial cells [24]. The TPA-induced loss of GJC
was correlated with the increased phosphorylation of Cx43
in these cells. However, the effects of treatment on the
internalization of Cx43 from the plasma membrane regions
were not addressed in this study. Treatment with vitamin K3
(menadione) has been shown to decrease GJC in WB-F344
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the activation of the EGF receptor and MAP kinase and this
resulted in increased phosphorylation of Cx43 [25]. The
effects of vitamin K3 treatment on GJC appeared to occur in
the absence of the loss of Cx43 from the plasma membrane.
EGF has also been reported to increase the expression of
Cx43 in porcine granulosa cells [26]. This change in Cx43
protein levels occurred in the absence of changes in Cx43
phosphorylation and may be involved in the up-regulation
of GJC in early folliculogenesis.
3.3. PDGF receptor tyrosine kinase
Disruption of GJC induced by the activated platelet-
derived growth factor (PDGF) receptor is rapid and transient
and appears to be complex in terms of the possible down-
stream effectors, since both PKC and MAP kinase have been
reported to be necessary to disrupt Cx43 function [66].
Disruption of GJC was correlated with the increase in Cx43
phosphorylation and required the tyrosine kinase activity of
the PDGFh receptor. Down-regulation of the TPA-sensitive
forms of PKC or treatment with the PD98059 MEK inhibitor
to down-regulate MAP kinase both reduced the PDGF-
induced effects on GJC and Cx43 phosphorylation. More
recent reports have suggested that the PDGF-induced disrup-
tion of Cx43 function did not rely solely on Cx43 phosphor-
ylation or on the activation of MAP kinase, but may have
required additional signaling pathways [67,68]. The site(s) of
serine phosphorylation induced by the activated PDGFh
receptor signaling pathways has not been characterized.
PDGF treatment also induced a rapid and transient
disruption of GJC in mesangial cells of the kidney glomer-
ulus [69]. This was correlated with the activation of Erk1/2
and the tyrosine phosphorylation of Cx43. PI3-kinase inhib-
itors blocked the tyrosine phosphorylation of Cx43 and the
activation of Erk in this system, suggesting a role for PI3
kinase in the regulation of Cx43 in the PDGF-induced
signaling in these cells. The kinase involved in the PDGF-
induced tyrosine phosphorylation of Cx43 in these cells was
not identified. Further studies will be necessary to elucidate
the complex molecular mechanisms that contribute to the
regulation of Cx43 following the activation of the PDGF
receptor and to identify the sites in Cx43 that are phosphor-
ylated by PDGF receptor-induced intracellular signaling.
3.4. VEGF receptor tyrosine kinase
Vascular endothelial growth factor (VEGF) binds to and
activates the tyrosine kinase activity of the VEGF receptor 2
(Flk-1 or KDR). The VEGF receptor is highly related to the
PDGF receptor family. Endothelial cells express multiple
connexins, including Cx43, Cx40 and Cx37. In a manner
that is similar to the EGF stimulation of epithelial cells
[53,54], VEGF-A treatment of human umbilical vein endo-
thelial cells resulted in a rapid and transient reduction in
GJC that correlated with increased Cx43 phosphorylation,and this phosphorylation appeared to occur on serine or
threonine residues [19]. Altered Cx43 localization at the
plasma membrane was not observed in this study. Activa-
tion of the VEGF receptor appeared to involve the down-
stream activation of an Src family member and MAP kinase
and both of these kinases appeared to have a role in the
induction of Cx43 phosphorylation. The disruption of
channel activity in the VEGF-A-treated cells was also
dependent upon the activation of the c-Src tyrosine kinase
and MAP kinase [19]. The ability of the connexin proteins
to form Cx43/Cx40 mixed gap junction channels further
complicates the regulation of GJC in vascular endothelial
cells [70,71]. Mixed connexin channels may be subject to
the regulation of GJC by pathways that target either the
Cx40 or Cx43 proteins. Additional studies will be required
to further characterize VEGF receptor-induced intracellular
signaling and the importance of this signaling pathway in
regulating GJC in vascular endothelial cells.
3.5. FGF receptor tyrosine kinase
Fibroblast growth factor (FGF) is a large family of
heparin-binding proteins that have potent mitogenic activity
for neural cells, cardiomyocytes and endothelial cells
[6,72,73]. Basic FGF (b-FGF or FGF-2) plays a role in
wound healing, angiogenesis, and cell proliferation and may
also participate in regulating GJC in the injured myocardi-
um. b-FGR has been shown to co-localize with Cx43 at the
plasma membrane in gap junction plaques in the intercalated
discs of cardiomyocytes and in the rat brain [74,75]. These
data suggested, but did not prove a physical association of
these two proteins. b-FGF has been shown to have both
long- and short-term effects on Cx43 [73]. Long-term
treatment (>6 h) stimulated GJC in cardiac fibroblasts and
up-regulated Cx43 mRNA and protein levels [27]. In
contrast, short-term treatment (30 min) with b-FGF was
associated with a fall in GJC, without a change in the Cx43
protein levels or loss of Cx43 from the plasma membrane.
This fall in GJC was associated with increased Cx43
phosphorylation on serine, although a tyrosine kinase in-
hibitor prevented these effects on GJC. Tyrosine phosphor-
ylation on Cx43 was not detected in this study, but a fraction
of the Cx43 in the b-FGF treated myocytes was precipitated
with a phosphotyrosine antibody. These data suggested that
b-FGF induced the association of Cx43 with a phosphotyr-
osine-containing protein(s) [27]. Whether or not this protein
might be the c-Src kinase that is activated by FGF receptor-
dependent signaling is not known.
In another study, FGF-1 or FGF-2 increased GJC in
primary cultures of embryonic chick lens cells without
detectable increases in the synthesis or assembly of gap
junctions [28]. FGF-2 induced a sustained activation of Erk
in the lens cells that was necessary for the increase in GJC.
This effect of sustained Erk activation on GJC differs from
the short-term transient activation of Erk that has been
associated with the disruption of GJC in other cell systems.
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Insulin or insulin-like growth factor (IGF) activates the
insulin receptor tyrosine kinase and induces the disruption
of Cx43 channels in a paired oocyte system [12]. The effects
of insulin on GJC were not observed with the expression of
a Cx43 mutant that was truncated at Met257 and thus lacked
the C-terminal cytoplasmic tail of Cx43. As mentioned
previously, the free carboxyl-terminal tail of Cx43,
expressed as a separate peptide, reconstituted the insulin-
induced disruption of GJC in oocytes that expressed a
truncated form of Cx43. These studies supported a ‘‘ball-
and-chain’’ type model for Cx43 channel gating. Amino
acids in the region between Gly261 and Pro280 of Cx43
appeared to be required for this effect on GJC. This region
contains the MAP kinase recognition sequence for Ser279
phosphorylation and part of the recognition sequence for
MAP kinase phosphorylation at the Ser282 site of Cx43
[12]. Activation of the insulin receptor is known to induce
MAP kinase activation [76], however, it is not known
whether the participation of MAP kinase was required for
the insulin-induced effects on GJC in the oocyte expression
system.
IGF induced the translocation and activation of PKCg,
increased serine phosphorylation of Cx43, and induced a
fall in GJC in rabbit lens epithelial cells [77]. PKCg
translocation induced an association between Cx43 and
PKCg as shown by co-immunoprecipitation studies. IGF
treatment increased diacylglycerol (DAG) and this stimu-
lated PKCg translocation and the increased phosphorylation
of Cx43 [77]. It is not known whether PKCg directly
phosphorylates Cx43 in this system or whether MAP kinase
participates in the induced Cx43 serine phosphorylation.
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The critical importance of phosphorylation of the tyro-
sine sites in Cx43 by v-Src was underscored by a recent
report that examined electrical coupling [39]. The actions of
v-Src on Cx43 most likely promoted channel closure by
decreasing P0 channel open probability, rather than by
diminishing channel unitary conductance, as was found to
be the case in the actions of PKC on Cx43 [56,78]. Cottrell
et al. [39] also detected differences in the dye selectivity
profiles of the phosphotyrosine-containing Cx43 channels in
the v-Src cells. These authors proposed a model for further
testing that suggests that PKC-mediated phosphorylation of
Cx43 at the distal Ser 368 site may induce a conformational
change at the carboxyl-terminus of the protein that some-
how affects the channel pore and alters unitary conductance.
Whereas, the phosphorylation induced by c-Src or MAP
kinase, occurring at the proximal end of the carboxyl-tail
leads to effects on channel open probability. A challenge for
future studies will be to design ways to test this model and
to address the question of the physiological significance ofthe different ways in which Cx43 is regulated by phosphor-
ylation events that occur at different molecular sites in the
C-terminal domain of the protein.5. Phosphorylation of other connexins by tyrosine
protein kinases
Less is known about the regulation of other connexins by
tyrosine protein kinases. As mentioned previously, there is
one report that the EGF receptor can directly phosphorylate
Cx32 in a cell-free system [64], but whether this occurs in
vivo is unknown. Traub et al. [79] have reported that murine
Cx37 expressed in HeLa cells is phosphorylated mainly on
serine with less phosphorylation on tyrosine and little
phosphorylation on threonine. Junctional conductance was
not inhibited in these cells. Hertlein et al. [80] found that
murine Cx45 expressed in HeLa cells also contained some
phosphotyrosine and phosphothreonine, but was primarily
phosphorylated on serine (z 90%) at nine sites in the C-
terminus of the protein. These cells were coupled through
gap junctions, so the level of tyrosine phosphorylation or the
site(s) of tyrosine phosphorylation did not interfere with
GJC. These studies indicate that other connexins can be
phosphorylated on tyrosine, at least when expressed in
transformed cells, and this phosphorylation is not necessar-
ily associated with a disruption of GJC.
Treatment with pervanadate enhanced the tyrosine phos-
phorylation on Cx45 in the HeLa cells and increased
phosphorylation was associated with a 44% fall in junction-
al conductance [81]. Increased Cx45 phosphorylation was
not blocked in cells pretreated with the PD98059 MEK
inhibitor and EGF did not induce a phosphorylation increase
on Cx45, indicating that MAP kinases were not likely to be
involved in the pervanadate-induced phosphorylation. The
increased phosphorylation on Cx45 presumably occurred
through the inhibition of tyrosine phosphatase activity and
the increased level of tyrosine phosphorylation or the
induced sites of phosphorylation led to the disruption of
GJC. The sites for tyrosine phosphorylation in Cx45 have
not been characterized. Regulation of channel function in
this case appeared to be through the modulation of channel
open probability [81] as has also been shown for the v-Src
induced disruption of GJC by tyrosine phosphorylation of
Cx43 [39].6. Regulation by protein phosphatases
The regulation of connexin phosphorylation by protein
phosphatases is another important aspect of intracellular
signaling that affects the connexin proteins. Phosphatases
attenuate the activity of protein kinases and terminate activ-
ities that are transiently induced by different stimulatory
events. Phosphatases are themselves subject to regulation
by post-translational modifications, secondary messengers,
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ization [35]. All of these regulatory events may be altered by
the activation of intracellular signaling pathways. Phospha-
tases are thought to be involved in the trafficking and
degradation of connexins and in the regulation of phosphor-
ylation-induced channel gating, and they may also be impor-
tant in regulating the interaction of connexins with other
cellular proteins. The regulation of connexins by protein
phosphatases is not covered in this review, but has been
critically reviewed elsewhere [29,82].7. Connexin regulation in transformed cells
A number of studies have examined the role of connexins
in the regulation of growth in transformed cells [83–87].
Loss of connexin expression or function has been associated
with increased rates of cell proliferation and loss of anchor-
age-dependent growth and the re-expression of connexins in
transformed cells has been shown to slow cell proliferation.
Many of these studies have examined homologous cell–cell
communication. However, another important aspect is how
transformed cells communicate with surrounding ‘‘normal’’
cells. Cai et al. [88] found that the co-culture of EVC304
endothelial cells with human breast cancer cells induced a
rapid and transient fall in GJC and the appearance of
phosphotyrosine on Cx43. These authors speculated that
this fall in GJC might contribute to extravasation of tumor
cells during metastasis. Others have suggested that disrupted
GJC, together with effects on cell adhesion molecules, may
be important in determining the metastatic potential of
transformed cells [89,90]. Co-culture studies have shown
that non-transformed cells can decrease the ability of trans-
formed cells to grow as foci [91]. Goldberg et al. [92] used
anti-sense technology to demonstrate that these growth
suppressive effects of co-culture required the presence of
Cx43 and/or GJC.
Some polyetherurethane materials used in bioimplants
have been shown to induce tumors in rats [93] and to inhibit
GJC in cultures of V79 Chinese hamster fibroblasts [94].
Ichikawa and Tsuchiya [95] examined the effects of these
biomaterials in Balb/c 3T3 A31-1-1 cells transfected with
Cx43 and found a decreased effect of polyetherurethanes on
GJC in cells that expressed a Tyr265Phe Cx43 mutant
compared to cells that expressed wild-type Cx43. They
concluded that phosphorylation of Tyr265 of Cx43 was a
key step in the reduction of GJC induced by the exposure of
the cells to these materials and suggested that tyrosine
phosphorylation of Cx43 and down-regulation of GJC
may contribute to the tumorigenic potential of these bio-
materials.
Qin et al. [96] found that the expression of Cx43 or Cx26
in MDA-MB-231 human breast tumor cells did not achieve
the expected increases in GJC, but did suppress tumor
growth when the cells were implanted into the mammary
fat pads of nude mice. Cx43 was cytoplasmically localizedin the cells and not found in gap junction plaques. Both the
Cx43 and Cx26 over-expressing cells demonstrated de-
creased levels of FGF receptor-3 as compared to the parental
cells and the authors suggested that connexins had a GJC-
independent effect on the regulation of genes involved in
cell growth. Krutovskikh et al. [97] found that the expres-
sion of a dominant negative transport-deficient mutant of
Cx43 to down-regulate GJC in a rat bladder carcinoma cell
line did not significantly enhance the growth of the trans-
fected cells in nude mice as expected. This also suggested a
growth suppressive function of Cx43 that was independent
of GJC.
Moorby and Patel [98] found that transient expression of
only the C-terminal cytoplasmic tail portion of Cx43 (aa
243–382) in Neuro2a cells was sufficient to suppress cell
growth. The C-terminal tail protein was distributed through-
out the cytoplasm suggesting that membrane localization of
the protein and GJC were not required for the effects on cell
growth. Zhang et al. [99] also reported that full-length Cx43
is not required for growth suppressive effects. These authors
found that the C-terminal portion of the protein (aa 147–
382, containing transmembrane sequences, but lacking the
N-terminus, first extracellular loop, and the intracellular
loop) was sufficient to reduce the proliferation of U2OS
osteosarcoma cells. The expression of this N-terminally
truncated Cx43 reduced the levels of Skp2, a human F-
box protein that regulates ubiquitination of the p27 cell
cycle inhibitor when expressed in U2OS or COS-7 cells.
They proposed that Cx43 might function as a tumor-sup-
pressor gene by targeting Skp2 and increasing the levels of
p27 in a manner that was independent of GJC.
However, studies by Omori and Yamasaki [100] have
demonstrated that Cx43 without the C-terminal tail (trun-
cated at aa 239), when expressed in HeLa cells, suppressed
anchorage-independent cell growth and delayed the appear-
ance of tumors in nude mice, without an effect on cell
proliferation. In these studies, it was the loss of the C-
terminal tail of Cx43 that induced a negative cell growth
control capacity on Cx43. Clearly the effects of Cx43 on
cell proliferation and tumorigenic potential are complex and
may be somewhat cell type-specific. It is not clear in these
studies utilizing the expression of different deletion mutants
of Cx43, how the mutant proteins were post-translationally
modified and how this affected their localization, turnover
and interactions with other cellular proteins.8. Future directions
There are a number of outstanding issues that need to be
addressed to achieve a better understanding of the regulation
of connexins by protein phosphorylation induced by the
activation of tyrosine kinase-dependent intracellular signal-
ing pathways. New sites of phosphorylation and additional
kinases that target connexins have been uncovered in recent
years and have added to our knowledge of how phosphor-
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hormone (FSH) has been reported to induce the phosphor-
ylation of Cx43 at four sites near the C-terminus at Ser365,
Ser368, Ser369, and Ser373 and to increase Cx43 protein
levels [102]. A Cx43 mutant that lacked all of these serine
sites demonstrated severely reduced dye transfer activity
when expressed in HeLa cells, suggesting a functional role
for some or all of these serine sites. Casein kinase I
phosphorylation of Cx43 on the Ser325, Ser328 and/or
Ser330 sites appears to be involved in the assembly of
gap junctions [14,101]. Whereas, the tyrosine phosphoryla-
tion of Cx43 by v-Src and the serine phosphorylation of
Cx43 by MAP kinase appear to be important in the
regulation of P0 channel open probability [39]. In the case
of PKC-induced phosphorylation of Cx43 at the Ser368 site
a reduction was found in the channel unitary conductance
[56]. These studies begin to address the mechanics of
channel regulation by protein phosphorylation. However,
it is still not clear what these alterations in the electrophys-
iological properties of gap junctions mean in terms of the
biological consequences of connexin phosphorylation. And,
in those instances where connexin phosphorylation does not
appear to be required for the disruption of GJC, there may
be other consequences of protein phosphorylation, such as
the creation or disruption of binding sites that affect the
ability of Cx43 to provide a scaffolding function that is
important to the assembly of protein complexes that may be
involved in mediating Cx43’s biological effects.
In addition to effects on channel gating and gap junction
assembly, connexin phosphorylation may affect protein
stability and regulate protein degradation by proteosomal
and lysosomal mechanisms [103,104]. Much like the serine
phosphorylation of h-catenin induced by glycogen synthase
kinase 3 (GSK3), which targets h-catenin for proteosomal
degradation, phosphorylation destabilized Cx43 and tar-
geted the protein for proteosomal degradation in lens
epithelial cells [103]. Treating the cells with proteosomal
inhibitors stabilized the phosphorylated form of the Cx43
protein in these cells. Thus, protein stability is another
manner is which connexin function may be regulated by
protein phosphorylation events, but this is an area in which
much is currently unknown.
Another aspect of connexin phosphorylation for which
there is very little data is the issue of the stoichiometry of
phosphorylation. Although specific sites of phosphorylation
have been identified, and in the case of v-Src-induced
tyrosine phosphorylation of Cx43, this phosphorylation
appears to down-regulate GJC through a reduction in P0,
we do not know the stoichiometry of the phosphorylation
events required to induce this effect. A connexin channel is
made up of 12 connexin proteins and at this point we have
no idea how many of these molecules are phosphorylated in
vivo. Nor do we know how many phosphorylation events
are sufficient to alter channel properties or to alter connexin
protein turnover. In one study of v-Src-induced Cx43
phosphorylation, essentially all of the Cx43 in the celllysates was removed by repeated immunoprecipitations with
a phosphotyrosine antibody [11]. This suggested that all
Cx43 molecules were tyrosine-phosphorylated in cells
expressing a highly active tyrosine kinase. But this does
not answer the question of how many phosphorylation
events are minimally required to disrupt GJC. In the studies
of Huang et al. [21], the transient expression of the Tyr265-
Ala Cx43 mutant in airway epithelial cells blocked the
TNFa-induced disruption of GJC that appeared to be c-
Src-dependent. Since these cells also endogenously
expressed wild-type Cx43, channel closure may have been
blocked by preventing tyrosine phosphorylation on some
but perhaps not all, of the connexin proteins in a gap
junction channel. This may mean that full phosphorylation
of the available sites in all connexins comprising a channel
was not required for the functional effects.
An additional aspect of the regulation of gap junctions
that needs further study is the mechanism of channel gating.
Several studies have demonstrated a reconstituted system of
channel closure with the expression of the C-terminal tail of
Cx43 as a separate peptide in oocytes that expressed
truncated forms of Cx43 [12,40]. These data are consistent
with a ‘‘particle-receptor’’ model for channel closure. How-
ever, this does not rule out the possible contributions of
connexin-interacting proteins to channel regulation. More-
over, very little is known about the possible contributions of
other parts of the connexin protein that may serve to form
the ‘‘receptor’’ (such as the intracellular loop) in mediating
channel regulation. Clearly, these are several areas in the
field of connexin research that await additional research or
significant conceptual or technical breakthroughs to extend
our understanding of how GJC is regulated by the phos-
phorylation of connexins induced by the activation of
intracellular signaling pathways.Acknowledgements
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